Impact of treatment with pravastatin on delayed ischemic disease and mortality after aneurysmal subarachnoid hemorrhage
Ulrich Jaschinski(University Hospital Augsburg), H. Forst(Ludwig-Maximilians-Universität München), K. Scherer(University Hospital Augsburg), M. Lichtwarck(University Hospital Augsburg)
Cited by 19
Related Papers
Stress doses of hydrocortisone reverse hyperdynamic septic shock
|Critical Care Medicine|1999|896
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
|Intensive Care Medicine|2007|620
Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit
|Open Forum Infectious Diseases|2018|530
Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study
|The Lancet Respiratory Medicine|2021|169
A comparison of the adrenocortical response during septic shock and after complete recovery
|Intensive Care Medicine|1996|157